Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
Malak Rizk, Şükrü Tüzmen Molecular Biology and Genetics Program, Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University (EMU), Famagusta, North Cyprus, Turkey Abstract: RNA interference (RNAi) is a naturally existing endogenous mechanism for posttranscripti...
Saved in:
Main Authors: | Rizk M (Author), Tüzmen S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran
by: Di Stefano V, et al.
Published: (2022) -
Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
by: Dixon S, et al.
Published: (2023) -
RNA Interference
Published: (2016) -
RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models
by: Lin ZC, et al.
Published: (2024) -
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
by: Chantal M. Ferguson, et al.
Published: (2020)